Latest filing published 19 Jan 2023 for Idera Pharmaceuticals, INC..
Insider track record
No signal scores available.
Andrew R. Jordan: trading record in brief
Andrew R. Jordan is a declared insider of Idera Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 28 September 2022 and the latest from 17 January 2023.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 19 January 2023 with an option exercise in Idera Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Andrew R. Jordan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 402,529 sharesCommon StockSEC:0001104659-23-005137:0
- 261,718 shares0Common StockSEC:0001415889-23-000766:0
- 651,364 sharesCommon Stock, par value $0.001SEC:0001104659-22-104793:0
3 of 3 declarations